Search research articles
Contact Us
Filters
Showing results (21-30 of 155) with videos related to
Page
of 16
Sort By:
Surgical Neurology International
|
December 19, 2015
Cranial and spinal leptomeningeal dissemination in esthesioneuroblastoma: Two reports of distant central nervous system metastasis and rationale for treatment
Walavan Sivakumar, Nathan Oh, Aaron Cutler, et al.
Journal of Neuro-Oncology
|
February 16, 2024
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors
Lisa M Arnold, Yoji Hoshina, Hyejung Lee, et al.
Current Neurology and Neuroscience Reports
|
March 9, 2017
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M
Michael Karsy, Jian Guan, Adam L Cohen, et al.
Journal of Neuro-Oncology
|
June 28, 2022
Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis
Savannah Gelhard, Amiee Maxwell, Howard Colman, et al.
Neuro-Oncology Practice
|
September 18, 2023
An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah
Emma R Earl, Howard Colman, Joe Mendez, et al.
Cancer Reports (Hoboken, N.J.)
|
June 17, 2021
First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma
Xuechen Wang, Benjamin Haaland, Siwen Hu-Lieskovan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
Precision Medicine for Primary Central Nervous System Tumors: Are We There Yet?
Franziska Maria Ippen, Howard Colman, Martin J van den Bent, et al.
Current Oncology Reports
|
December 3, 2010
Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatments
Evanthia Galanis, Wenting Wu, Jann Sarkaria, et al.
ACG Case Reports Journal
|
March 14, 2017
A 30-Year-Old Man with Three Primary Malignancies: A Case of Constitutional Mismatch Repair Deficiency
William Rengifo-Cam, Kory Jasperson, Ignacio Garrido-Laguna, et al.
Oncotarget
|
November 17, 2016
IGFBP2 expression predicts IDH-mutant glioma patient survival
Lin Eric Huang, Adam L Cohen, Howard Colman, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 155) with videos related to
Sort By:
Page
of 16
Surgical Neurology International
|
December 19, 2015
Cranial and spinal leptomeningeal dissemination in esthesioneuroblastoma: Two reports of distant central nervous system metastasis and rationale for treatment
Walavan Sivakumar, Nathan Oh, Aaron Cutler, et al.
Journal of Neuro-Oncology
|
February 16, 2024
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors
Lisa M Arnold, Yoji Hoshina, Hyejung Lee, et al.
Current Neurology and Neuroscience Reports
|
March 9, 2017
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M
Michael Karsy, Jian Guan, Adam L Cohen, et al.
Journal of Neuro-Oncology
|
June 28, 2022
Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis
Savannah Gelhard, Amiee Maxwell, Howard Colman, et al.
Neuro-Oncology Practice
|
September 18, 2023
An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah
Emma R Earl, Howard Colman, Joe Mendez, et al.
Cancer Reports (Hoboken, N.J.)
|
June 17, 2021
First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma
Xuechen Wang, Benjamin Haaland, Siwen Hu-Lieskovan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
Precision Medicine for Primary Central Nervous System Tumors: Are We There Yet?
Franziska Maria Ippen, Howard Colman, Martin J van den Bent, et al.
Current Oncology Reports
|
December 3, 2010
Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatments
Evanthia Galanis, Wenting Wu, Jann Sarkaria, et al.
ACG Case Reports Journal
|
March 14, 2017
A 30-Year-Old Man with Three Primary Malignancies: A Case of Constitutional Mismatch Repair Deficiency
William Rengifo-Cam, Kory Jasperson, Ignacio Garrido-Laguna, et al.
Oncotarget
|
November 17, 2016
IGFBP2 expression predicts IDH-mutant glioma patient survival
Lin Eric Huang, Adam L Cohen, Howard Colman, et al.
Page
of 16